Provepharm is currently owned by ARCHIMED, through MED II, since 2018.

When did ARCHIMED acquire Provepharm?

ARCHIMED acquired Provepharm in 2018 (active for 8 years).

Provepharm

Biotech·

France·Active·8yr hold

Provepharm is a healthcare company, headquartered in France.

Entry

2018

Hold

8yr

Status

Active

Est. EV

–

Most recent investor

2 ownership periods

HQFrance

SectorHealthcare

Founded in 1998 in France, Provepharm is a leading biopharmaceutical company that uses its expertise in fine chemistry for the…Read full notes

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

2 portfolio peers in MED II

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings